Showing results (411-420 of 1,028) with videos related to
Sort By:
Pageof 103
The Lancet. Respiratory Medicine|April 11, 2014
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trialGanesh Raghu, David Lynch, J David Godwin, et al.The Lancet. Respiratory Medicine|March 27, 2019
The microbiome and tuberculosis: state of the art, potential applications, and defining the clinical research agendaCharissa C Naidoo, Georgina R Nyawo, Benjamin G Wu, et al.The Lancet. Respiratory Medicine|April 15, 2017
Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trialRafael Rosell, Urania Dafni, Enriqueta Felip, et al.The Lancet. Respiratory Medicine|May 13, 2014
Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysisLone Simonsen, Robert J Taylor, Cynthia Schuck-Paim, et al.The Lancet. Respiratory Medicine|May 13, 2014
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant dataStella G Muthuri, Sudhir Venkatesan, Puja R Myles, et al.The Lancet. Respiratory Medicine|March 30, 2019
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trialMartin Reck, Tony S K Mok, Makoto Nishio, et al.The Lancet. Respiratory Medicine|February 27, 2021
Balancing the needs of the many and the few: where next for adult asthma guidelines?Dominick E Shaw, Liam G Heaney, Mike Thomas, et al.The Lancet. Respiratory Medicine|November 14, 2021
Intravenous immunoglobulins in patients with COVID-19-associated moderate-to-severe acute respiratory distress syndrome (ICAR): multicentre, double-blind, placebo-controlled, phase 3 trialAurélien Mazeraud, Matthieu Jamme, Rossella Letizia Mancusi, et al.The Lancet. Respiratory Medicine|November 10, 2021
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID): a factorial, randomised, controlled trialJozefien Declercq, Karel F A Van Damme, Elisabeth De Leeuw, et al.The Lancet. Respiratory Medicine|January 28, 2014
Lung cancer: potential targets for immunotherapyEric Tartour, Laurence ZitvogelPageof 103